Need help finding what you are looking for?
Contact Us
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1388778
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1388778
Biomarker Discovery Outsourcing Services Market, By Type, By Therapeutic Area, By Discovery Phase, By End Use, By Country, and By Region -Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
PUBLISHED:
PAGES: 311 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
REPORT HIGHLIGHT
Biomarker discovery outsourcing services market size was valued at USD 11,210 Million in 2022, expanding at a CAGR of 23.5% from 2023 to 2030.
The biomarker discovery outsourcing services market is a growing sector within the broader pharmaceutical and biotechnology sector. Biomarkers are quantifiable indicators of molecular or biological processes with a wide range of applications in areas including disease diagnosis, personalized medicine, and drug development. Biomarker discovery outsourcing services provide specialized expertise and resources to help academic research institutions, pharmaceutical companies, and other organizations validate, utilize, and identify biomarkers for several purposes.
Biomarker Discovery Outsourcing Services Market- Market Dynamics
The rising prevalence of chronic diseases is propelling market growth
The increase in the prevalence of chronic diseases including cancer, cardiovascular diseases, neurodegenerative conditions, and diabetes are major contributing factors to the market expansion. Additionally, the growth of companion diagnostics, a focus on liquid biopsy for cancer detection, and the use of machine learning and artificial intelligence for data analysis are emerging trends fueling the demand of the market. Moreover, as personalized medicine becomes more prevalent and as the demand for targeted therapies and diagnostic tools increases, thus, the demand for biomarker discovery outsourcing services market is expected to continue growing. Furthermore, biomarker discovery is a crucial component of healthcare and life sciences research. It aids in developing targeted therapies, understanding disease mechanisms, and the early detection of diseases. This also led to a rising demand for outsourcing services to expedite biomarker research.
Biomarker Discovery Outsourcing Services Market- Key Insights
- As per the analysis shared by our research analyst, the global biomarker discovery outsourcing services market is estimated to grow annually at a CAGR of around 23.5% over the forecast period (2023-2030)
- The biomarker discovery outsourcing services industry is projected to grow at a significant rate due to the growing demand for personalized medicine
- Based on type segmentation, surrogate endpoints was predicted to show maximum market share in the year 2022
- Based on end use segmentation, biotechnology companies was the leading type in 2022
- Based on Region, North America was the leading revenue generator in 2022.
Biomarker Discovery Outsourcing Services Market- Segmentation Analysis:
The global biomarker discovery outsourcing services market is segmented on the basis of type, therapeutic area, discovery phase, end use, and region.
The market is divided into four categories based on type: surrogate endpoints, predictive biomarkers, safety biomarkers, prognostic biomarkers, and others. The surrogate endpoints segment is accounted to witness the highest growth rate. To accomplish crucial objectives such as disease progression or patient survival, clinical trials can take years and need substantial resources. Surrogate biomarkers enables for more efficient and shorter clinical trials because they can offer early indications of treatment efficacy, such advantages are projected to drive the segment's growth
The market is divided into two categories based on end use: biotechnology companies, pharmaceutical companies, and others. The biotechnology companies segment is likely to maintain its dominance over the forecast period. Outsourcing enables biotechnology companies to tap into the expertise of specialized service providers, such as Contract Research Organizations (CROs). Outsourcing biomarker discovery might be cost-effective over maintaining in-house teams, equipment, and infrastructure. Biotechnology companies can allocate resources more effectively by focusing on their core competencies, like therapeutic research or drug development.
Biomarker Discovery Outsourcing Services Market- Geographical Insights
By regional analysis, the biomarker discovery outsourcing services market can be segmented into North America, Asia Pacific, Europe, and the Rest of the World. North America is likely to dominate the market due to its access to innovating technologies, robust biotech industry, regulatory expertise, and advanced healthcare infrastructure. In the region, regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the Canadian Food Inspection Agency (CFIA), have renowned regulatory infrastructure for biomarkers in advanced drugs and diagnostics. This regulatory clarity supports validation efforts and biomarker research. Furthermore, Asia Pacific is anticipated to witness maximum growth during the forecast period. In the region, various economies such as China and India are considered emerging markets for biotechnology and pharmaceuticals. To these countries, the cost-effectiveness of outsourcing biomarker discovery projects can be attractive to worldwide pharmaceutical business.
Biomarker Discovery Outsourcing Services Market- Competitive Landscape:
Businesses in this space typically provide a vast range of services, from sample collection to data analysis, to meet the diverse needs of biotechnology pharmaceutical clients. Various specialized biotechnology companies and contract research organizations (CROs) offer biomarker discovery services. These companies have the infrastructure and expertise to carry out biomarker-related research and development on behalf of their clients. The market is influenced by the advancement of technology in proteomics and genomics which allow more comprehensive biomarker discovery. Market players operating in this sector are adopting several strategic initiatives, such as collaborations, partnerships, and new product launches, to maintain their business foothold in the market.
Recent Developments:
In January 2022, Inotiv, Inc. and Synexa Life Sciences announced that they intend to form a collaboration that will accelerate Inotiv's development of biomarkers important to the understanding of efficacy and safety of novel biotherapeutics, improve the business preclinical discovery and safety assessment services.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET KEY PLAYERS
- Thermo Fisher Scientific Inc.
- Laboratory Corporation of America Holdings
- GHO Capital
- ICON plc
- Agilent
- Proteome Sciences
- Charles River Laboratories.
- Eurofins Scientific
- Celerion
- Evotec
- Parexel International (MA) Corporation
GLOBAL BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET, BY TYPE
- Surrogate endpoints
- Predictive biomarkers
- Safety biomarkers
- Prognostic biomarkers
- Others
GLOBAL BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET, BY THERAPEUTIC AREA
- Autoimmune Diseases
- Oncology
- Cardiology
- Neurology
- Others
GLOBAL BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET, BY DISCOVERY PHASE
- Biomarker Selection
- Biomarker Identification
- Biomarker Validation
- Biomarker Panel Development
- Biomarker Profiling
GLOBAL BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET, BY END USE
- Biotechnology Companies
- Pharmaceutical Companies
- Others
GLOBAL BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Product Code: ANV1840
Table of Contents
1. Biomarker Discovery Outsourcing Services Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Biomarker Discovery Outsourcing Services Market Snippet by Type
- 2.1.2. Biomarker Discovery Outsourcing Services Market Snippet by Therapeutic Area
- 2.1.3. Biomarker Discovery Outsourcing Services Market Snippet by Discovery Phase
- 2.1.4. Biomarker Discovery Outsourcing Services Market Snippet by End Use
- 2.1.5. Biomarker Discovery Outsourcing Services Market Snippet by Country
- 2.1.6. Biomarker Discovery Outsourcing Services Market Snippet by Region
- 2.2. Competitive Insights
3. Biomarker Discovery Outsourcing Services Key Market Trends
- 3.1. Biomarker Discovery Outsourcing Services Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Biomarker Discovery Outsourcing Services Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Biomarker Discovery Outsourcing Services Market Opportunities
- 3.4. Biomarker Discovery Outsourcing Services Market Future Trends
4. Biomarker Discovery Outsourcing Services Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Biomarker Discovery Outsourcing Services Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Biomarker Discovery Outsourcing Services Market Landscape
- 6.1. Biomarker Discovery Outsourcing Services Market Share Analysis, 2022
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Biomarker Discovery Outsourcing Services Market - By Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2022&2030 (%)
- 7.1.2. Surrogate endpoints
- 7.1.3. Predictive biomarkers
- 7.1.4. Safety biomarkers
- 7.1.5. Prognostic biomarkers
- 7.1.6. Others
8. Biomarker Discovery Outsourcing Services Market - By Therapeutic Area
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Therapeutic Area, 2022&2030 (%)
- 8.1.2. Autoimmune Diseases
- 8.1.3. Oncology
- 8.1.4. Cardiology
- 8.1.5. Neurology
- 8.1.6. Others
9. Biomarker Discovery Outsourcing Services Market - By Discovery Phase
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Discovery Phase, 2022&2030 (%)
- 9.1.2. Biomarker Selection
- 9.1.3. Biomarker Identification
- 9.1.4. Biomarker Validation
- 9.1.5. Biomarker Panel Development
- 9.1.6. Biomarker Profiling
10. Biomarker Discovery Outsourcing Services Market - By End Use
- 10.1. Overview
- 10.1.1. Segment Share Analysis, By End Use, 2022&2030 (%)
- 10.1.2. Biotechnology Companies
- 10.1.3. Pharmaceutical Companies
- 10.1.4. Others
11. Biomarker Discovery Outsourcing Services Market- By Geography
- 11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
- 11.2. North America
- 11.2.1. Overview
- 11.2.2. Biomarker Discovery Outsourcing Services Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.2.8. U.S.
- 11.2.8.1. Overview
- 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.2.8.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.2.8.4. U.S. Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
- 11.2.8.5. U.S. Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
- 11.2.8.6. U.S. Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.2.9. Canada
- 11.2.9.1. Overview
- 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.2.9.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.2.9.4. Canada Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
- 11.2.9.5. Canada Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
- 11.2.9.6. Canada Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.3. Europe
- 11.3.1. Overview
- 11.3.2. Biomarker Discovery Outsourcing Services Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.3.8. Germany
- 11.3.8.1. Overview
- 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.3.8.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.3.8.4. Germany Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
- 11.3.8.5. Germany Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
- 11.3.8.6. Germany Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.3.9. Italy
- 11.3.9.1. Overview
- 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.3.9.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.3.9.4. Italy Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
- 11.3.9.5. Italy Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
- 11.3.9.6. Italy Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.3.10. United Kingdom
- 11.3.10.1. Overview
- 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.3.10.4. United Kingdom Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
- 11.3.10.5. United Kingdom Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
- 11.3.10.6. United Kingdom Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.3.11. France
- 11.3.11.1. Overview
- 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.3.11.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.3.11.4. France Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
- 11.3.11.5. France Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
- 11.3.11.6. France Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.3.12. Russia
- 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.3.12.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.3.12.3. Russia Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
- 11.3.12.4. Russia Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
- 11.3.12.5. Russia Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.3.13. Netherlands
- 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.3.13.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.3.13.3. Netherlands Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
- 11.3.13.4. Netherlands Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
- 11.3.13.5. Netherlands Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.3.14. Sweden
- 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.3.14.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.3.14.3. Sweden Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
- 11.3.14.4. Sweden Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
- 11.3.14.5. Sweden Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.3.15. Poland
- 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.3.15.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.3.15.3. Poland Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
- 11.3.15.4. Poland Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
- 11.3.15.5. Poland Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.3.16. Rest of Europe
- 11.3.16.1. Overview
- 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.3.16.4. Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
- 11.3.16.5. Rest of the Europe Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
- 11.3.16.6. Rest of the Europe Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Biomarker Discovery Outsourcing Services Key Manufacturers in Asia Pacific
- 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 11.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.4.5. Asia Pacific Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
- 11.4.6. Asia Pacific Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
- 11.4.7. Asia Pacific Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.4.8. India
- 11.4.8.1. Overview
- 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.4.8.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.4.8.4. India Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
- 11.4.8.5. India Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
- 11.4.8.6. India Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.4.9. China
- 11.4.9.1. Overview
- 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.4.9.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.4.9.4. China Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
- 11.4.9.5. China Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
- 11.4.9.6. China Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.4.10. Japan
- 11.4.10.1. Overview
- 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.4.10.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.4.10.4. Japan Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
- 11.4.10.5. Japan Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
- 11.4.10.6. Japan Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.4.11. South Korea
- 11.4.11.1. Overview
- 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.4.11.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.4.11.4. South Korea Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
- 11.4.11.5. South Korea Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
- 11.4.11.6. South Korea Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.4.12. Australia
- 11.4.12.1. Overview
- 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.4.12.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.4.12.4. Australia Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
- 11.4.12.5. Australia Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
- 11.4.12.6. Australia Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.4.13. Thailand
- 11.4.13.1. Overview
- 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.4.13.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.4.13.4. Thailand Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
- 11.4.13.5. Thailand Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
- 11.4.13.6. Thailand Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.4.14. Indonesia
- 11.4.14.1. Overview
- 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.4.14.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.4.14.4. Indonesia Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
- 11.4.14.5. Indonesia Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
- 11.4.14.6. Indonesia Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.4.15. Philippines
- 11.4.15.1. Overview
- 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.4.15.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.4.15.4. Philippines Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
- 11.4.15.5. Philippines Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
- 11.4.15.6. Philippines Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.4.16. Rest of APAC
- 11.4.16.1. Overview
- 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.4.16.4. Rest of APAC Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
- 11.4.16.5. Rest of APAC Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
- 11.4.16.6. Rest of APAC Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.5. Latin America
- 11.5.1. Overview
- 11.5.2. Biomarker Discovery Outsourcing Services Key Manufacturers in Latin America
- 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 11.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.5.5. Latin America Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
- 11.5.6. Latin America Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
- 11.5.7. Latin America Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.5.8. Brazil
- 11.5.8.1. Overview
- 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.5.8.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.5.8.4. Brazil Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
- 11.5.8.5. Brazil Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
- 11.5.8.6. Brazil Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.5.9. Mexico
- 11.5.9.1. Overview
- 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.5.9.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.5.9.4. Mexico Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
- 11.5.9.5. Mexico Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
- 11.5.9.6. Mexico Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.5.10. Argentina
- 11.5.10.1. Overview
- 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.5.10.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.5.10.4. Argentina Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
- 11.5.10.5. Argentina Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
- 11.5.10.6. Argentina Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.5.11. Colombia
- 11.5.11.1. Overview
- 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.5.11.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.5.11.4. Colombia Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
- 11.5.11.5. Colombia Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
- 11.5.11.6. Colombia Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.5.12. Rest of LATAM
- 11.5.12.1. Overview
- 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.5.12.4. Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
- 11.5.12.5. Rest of LATAM Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
- 11.5.12.6. Rest of LATAM Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.6. Middle East and Africa
- 11.6.1. Overview
- 11.6.2. Biomarker Discovery Outsourcing Services Key Manufacturers in Middle East and Africa
- 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.6.5. Middle East and Africa Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
- 11.6.6. Middle East and Africa Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
- 11.6.7. Middle East and Africa Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.6.8. Saudi Arabia
- 11.6.8.1. Overview
- 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.6.8.4. Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
- 11.6.8.5. Saudi Arabia Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
- 11.6.8.6. Saudi Arabia Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.6.9. United Arab Emirates
- 11.6.9.1. Overview
- 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.6.9.4. United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
- 11.6.9.5. United Arab Emirates Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
- 11.6.9.6. United Arab Emirates Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.6.10. Israel
- 11.6.10.1. Overview
- 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.6.10.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.6.10.4. Israel Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
- 11.6.10.5. Israel Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
- 11.6.10.6. Israel Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.6.11. Turkey
- 11.6.11.1. Overview
- 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.6.11.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.6.11.4. Turkey Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
- 11.6.11.5. Turkey Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
- 11.6.11.6. Turkey Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.6.12. Algeria
- 11.6.12.1. Overview
- 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.6.12.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.6.12.4. Algeria Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
- 11.6.12.5. Algeria Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
- 11.6.12.6. Algeria Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.6.13. Egypt
- 11.6.13.1. Overview
- 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.6.13.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.6.13.4. Egypt Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
- 11.6.13.5. Egypt Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
- 11.6.13.6. Egypt Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.6.14. Rest of MEA
- 11.6.14.1. Overview
- 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.6.14.4. Rest of MEA Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
- 11.6.14.5. Rest of MEA Market Size and Forecast, By Discovery Phase, 2018 - 2030 (US$ Million)
- 11.6.14.6. Rest of MEA Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
12. Key Vendor Analysis- Biomarker Discovery Outsourcing Services Industry
- 12.1. Competitive Dashboard
- 12.2. Company Profiles
- 12.2.1. Thermo Fisher Scientific Inc.
- 12.2.2. Laboratory Corporation of America Holdings
- 12.2.3. GHO Capital
- 12.2.4. ICON plc
- 12.2.5. Agilent
- 12.2.6. Proteome Sciences
- 12.2.7. Charles River Laboratories.
- 12.2.8. Eurofins Scientific
- 12.2.9. Celerion
- 12.2.10. Evotec
- 12.2.11. Parexel International (MA) Corporation
13. 360 Degree Analyst View
14. Appendix
- 14.1. Research Methodology
- 14.2. References
- 14.3. Abbreviations
- 14.4. Disclaimer
- 14.5. Contact Us
Product Code: ANV1840
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE Biomarker Discovery Outsourcing Services Market: Type Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Type
- TABLE Global Biomarker Discovery Outsourcing Services Market, by Type2018-2030 (USD Million)
- TABLE Biomarker Discovery Outsourcing Services Market: Therapeutic AreaSnapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Therapeutic Area
- TABLE Global Biomarker Discovery Outsourcing Services Market, by Therapeutic Area2018-2030 (USD Million)
- TABLE Biomarker Discovery Outsourcing Services Market: Discovery Phase Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Discovery Phase
- TABLE Global Biomarker Discovery Outsourcing Services Market, by Discovery Phase 2018-2030 (USD Million)
- TABLE Biomarker Discovery Outsourcing Services Market: End Use Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by End Use
- TABLE Global Biomarker Discovery Outsourcing Services Market, by End Use 2018-2030 (USD Million)
- TABLE Biomarker Discovery Outsourcing Services Market: Regional snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Region
- TABLE Global Biomarker Discovery Outsourcing Services Market, by Region 2018-2030 (USD Million)
- TABLE North America Biomarker Discovery Outsourcing Services Market, by Country, 2018-2030 (USD Million)
- TABLE North America Biomarker Discovery Outsourcing Services Market, by Type, 2018-2030 (USD Million)
- TABLE North America Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
- TABLE North America Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
- TABLE North America Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
- TABLE Europe Biomarker Discovery Outsourcing Services Market, by Country, 2018-2030 (USD Million)
- TABLE Europe Biomarker Discovery Outsourcing Services Market, by Type, 2018-2030 (USD Million)
- TABLE EuropeBiomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
- TABLE EuropeBiomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
- TABLE EuropeBiomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
- TABLE Asia Pacific Biomarker Discovery Outsourcing Services Market, by Country, 2018-2030 (USD Million)
- TABLE Asia Pacific Biomarker Discovery Outsourcing Services Market, by Type, 2018-2030 (USD Million)
- TABLE Asia Pacific Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
- TABLE Asia Pacific Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
- TABLE Asia Pacific Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
- TABLE Latin America Biomarker Discovery Outsourcing Services Market, by Country, 2018-2030 (USD Million)
- TABLE Latin America Biomarker Discovery Outsourcing Services Market, by Type, 2018-2030 (USD Million)
- TABLE Latin America Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
- TABLE Latin America Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
- TABLE Latin America Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
- TABLE Middle East and Africa Biomarker Discovery Outsourcing Services Market, by Country, 2018-2030 (USD Million)
- TABLE Middle East and Africa Biomarker Discovery Outsourcing Services Market, by Type, 2018-2030 (USD Million)
- TABLE Middle East and Africa Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
- TABLE Middle East and Africa Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
- TABLE Middle East and Africa Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.